Autologous hematopoietic stem cell transplantation followed by quadruple immunotherapy with dinutuximab beta, sargramostim, aldesleukin, and spironolactone for relapsed metastatic retinoblastoma

MeSH terms

• Antibodies, Monoclonal* / administration & dosage
• Antibodies, Monoclonal* / therapeutic use
• Antineoplastic Combined Chemotherapy Protocols* / therapeutic use
• Child, Preschool
• Combined Modality Therapy
• Female
• Hematopoietic Stem Cell Transplantation*
• Humans
• Immunotherapy / methods
• Male
• Neoplasm Recurrence, Local / drug therapy
• Neoplasm Recurrence, Local / pathology
• Retinal Neoplasms / drug therapy
• Retinal Neoplasms / pathology
• Retinal Neoplasms / therapy
• Retinoblastoma* / drug therapy
• Retinoblastoma* / pathology
• Retinoblastoma* / therapy
• Thrombopoietin / therapeutic use
• Transplantation, Autologous